We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy. Learn more here.Close Me
The Canadian Securities
Administrators released a consultation paper
today intended to build on earlier proposals to construct a
framework for the treatment of market participant collateral in
centrally cleared OTC derivatives transactions. Specifically, the
paper addresses the segregation of assets put forward as collateral
for OTC derivatives transactions cleared through a central
counterparty by customers that access the CCP indirectly through
clearing members. The paper also addresses the transfer of customer
collateral and customer positions upon the default or insolvency of
the clearing member of a CCP.
According to the CSA, the paper's recommendations are
intended to ensure that "CCPs clearing OTC derivatives possess
adequate rules and infrastructure to facilitate the segregation and
portability of collateral in a manner that provides market
participants with appropriate protections". To that end, the
paper recommends, among other things: (i) that clearing members be
required to segregate customer collateral from their own
proprietary assets and that the Complete Legal Segregation Model
(whereby all customers' collateral is permitted to be held on
an omnibus basis, but is recorded and attributed by both the CCP
and clearing member to each customer based on their collateral
advanced) be employed; (ii) that if CCPs or clearing members are
permitted to reinvest posted customer collateral, investments
should be restricted to instruments with minimal credit, market and
liquidity risk; (iii) that CCPs should hold customer collateral at
one or more supervised and regulated entities that have robust
accounting practices, safekeeping procedures and internal controls;
(iv) requiring CCPs to make the segregation and portability
arrangements contained in their rules and policies available to the
public in a clear and accessible manner; (v) that provincial market
regulators enact rules requiring that every OTC derivatives CCP be
structured to facilitate the portability of customer positions and
collateral; and (vi) that parties to an uncleared OTC derivatives
transaction be free to negotiate the level of segregation required
for collateral.
The CSA is accepting public comment on the consultation paper,
including with respect to the specific questions posed regarding
its recommendations, until April 10, 2012.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
On May 13, 2013, the Ontario Court of Appeal released its highly-anticipated decision in Royal Bank of Canada v. Samson Management & Solutions, a case concerning the enforceability of a "plain-vanilla standard form bank guarantee" in the context of a business loan.
In a recent case against an investment advisor and the firm who sponsored his registration to sell mutual funds and other financial products, the Ontario Court of Appeal upheld findings of direct and vicarious liability on a broker/dealer.
The Canadian Securities Administrators Derivatives Committee recently published the "CSA Consultation Paper 91-407 Derivatives: Registration" requesting comment.
Short term investors are extremely risk-adverse, and as we have seen, a large enough flight can turn into a stampede which can cause significant collateral damage.
In Kasten Energy Inc. v. Shamrock Oil & Gas Ltd., 2013 ABQB 63, the Alberta Court of Queen’s Bench considered the application of Kasten Energy Inc. to appoint a receiver over all of the assets and undertakings of Shamrock Oil & Gas Ltd..
Canadian managers of funds that are currently marketed into the European Union should be aware of the broad ambit of the Alternative Investment Fund Managers Directive and of the restrictions the AIFM Directive may impose as of July 22, 2013 on their activities in the EU.
Earlier this month, Saskatchewan Bill 65, The Securities Amendment Act, 2012, which will establish a framework for OTC derivatives regulation in that province, received Royal Assent.